These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 8947426)
21. [The use of drugs to improve athletic performance]. Verheij TC Ned Tijdschr Geneeskd; 1997 Nov; 141(48):2364-5. PubMed ID: 9550839 [No Abstract] [Full Text] [Related]
22. [The new frontiers of blood doping]. Lippi G; Franchini M Recenti Prog Med; 2002 Jan; 93(1):1-8. PubMed ID: 11850993 [TBL] [Abstract][Full Text] [Related]
23. Are drugs winning the games? Sullivan R; Song S Time; 2000 Sep; 156(11):90-2. PubMed ID: 11067230 [No Abstract] [Full Text] [Related]
24. Testing for recombinant erythropoietin. Delanghe JR; Bollen M; Beullens M Am J Hematol; 2008 Mar; 83(3):237-41. PubMed ID: 17918255 [TBL] [Abstract][Full Text] [Related]
25. Effects of exercise on the isoelectric patterns of erythropoietin. Lamon S; Martin L; Robinson N; Saugy M; Ceaurriz Jd; Lasne F Clin J Sport Med; 2009 Jul; 19(4):311-5. PubMed ID: 19638826 [TBL] [Abstract][Full Text] [Related]
26. A global strategy for prevention and detection of blood doping with erythropoietin and related drugs. Cazzola M Haematologica; 2000 Jun; 85(6):561-3. PubMed ID: 10870110 [No Abstract] [Full Text] [Related]
27. The hybrid algorithm (Hbmr) to fight against blood doping in sports. Sanchis-Gomar F; Martinez-Bello VE; Gomez-Cabrera MC; Viña J Scand J Med Sci Sports; 2010 Dec; 20(6):789-90; author reply 792-3. PubMed ID: 21182670 [No Abstract] [Full Text] [Related]
28. Effect of altitude on second-generation blood tests to detect erythropoietin abuse by athletes. Ashenden MJ; Gore CJ; Parisotto R; Sharpe K; Hopkins WG; Hahn AG Haematologica; 2003 Sep; 88(9):1053-62. PubMed ID: 12969814 [TBL] [Abstract][Full Text] [Related]
29. Haemoglobin mass in cyclists during stage racing. Schumacher YO; Pottgiesser T; Ahlgrim C; Ruthardt S; Dickhuth HH; Roecker K Int J Sports Med; 2008 May; 29(5):372-8. PubMed ID: 17614021 [TBL] [Abstract][Full Text] [Related]
30. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure. Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159 [TBL] [Abstract][Full Text] [Related]
31. The paradox of hematocrit in exercise physiology: which is the "normal" range from an hemorheologist's viewpoint? Brun JF; Bouchahda C; Chaze D; Benhaddad AA; Micallef JP; Mercier J Clin Hemorheol Microcirc; 2000; 22(4):287-303. PubMed ID: 11081466 [TBL] [Abstract][Full Text] [Related]
32. Recombinant erythropoietin to improve athletic performance. Adamson JW; Vapnek D N Engl J Med; 1991 Mar; 324(10):698-9. PubMed ID: 1994258 [No Abstract] [Full Text] [Related]
33. [Doctors belonging to the Senegalese Association of Sport Medicine and doping in sports: survey on knowledge and attitudes]. Dièye AM; Diallo B; Fall A; Ndiaye M; Cissè F; Faye B Sante; 2005; 15(3):167-70. PubMed ID: 16207578 [TBL] [Abstract][Full Text] [Related]
34. A third generation approach to detect erythropoietin abuse in athletes. Sharpe K; Ashenden MJ; Schumacher YO Haematologica; 2006 Mar; 91(3):356-63. PubMed ID: 16503554 [TBL] [Abstract][Full Text] [Related]
35. Beyond EPO. Corrigan B Clin J Sport Med; 2002 Jul; 12(4):242-4. PubMed ID: 12131058 [TBL] [Abstract][Full Text] [Related]
36. [The use of drugs to improve athletic performance]. Kuipers H; Hartgens F Ned Tijdschr Geneeskd; 1997 Oct; 141(41):1965-8. PubMed ID: 9550746 [TBL] [Abstract][Full Text] [Related]
37. Time and temperature dependant changes in red blood cell analytes used for testing recombinant erythropoietin abuse in sports. Robinson N; Mangin P; Saugy M Clin Lab; 2004; 50(5-6):317-23. PubMed ID: 15209440 [TBL] [Abstract][Full Text] [Related]
39. The influence of exercise on serum markers of altered erythropoiesis and the indirect detection models of recombinant human erythropoietin abuse in athletes. Schumacher YO; Temme J; Bueltermann D; Schmid A; Berg A Haematologica; 2003 Jun; 88(6):712-4. PubMed ID: 12801849 [No Abstract] [Full Text] [Related]
40. [Medication, athletes and doping regulations]. Hartgens F Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]